Market Cap 26.73M
Revenue (ttm) 6.40M
Net Income (ttm) -5.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -83.59%
Debt to Equity Ratio 0.03
Volume 500
Avg Vol 2,758
Day's Range N/A - N/A
Shares Out 41.82M
Stochastic %K 86%
Beta 0.76
Analysts Strong Buy
Price Target N/A

Company Profile

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications worldwide. The company's products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating. It is also involved in the development of dendrimer enhan...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 8532 2700
Fax: 61 3 9510 5955
Address:
4-6 Southampton Crescent, Abbotsford, Australia
Latest News on SPHRY
No data available.